Clinical Trials Logo

Clinical Trial Summary

This is a randomized, double-blinded, placebo-controlled trial of serratus plane blocks in subjects undergoing outpatient unilateral or bilateral breast surgery. Ninety subjects will be enrolled into the study at presurgical testing. Subjects will be stratified based on surgery type and randomized to receive a serratus plane block with either bupivicaine HCL or placebo. All patients will receive standard intraoperative anesthesia and standard postoperative pain control. The primary endpoint is the amount of opioid administered postoperatively. Secondary endpoints include postoperative pain intensity at timed intervals, amount of opioid administered intraoperatively and postoperatively, incidence of nausea and vomiting, time to discharge and patient satisfaction


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02865928
Study type Interventional
Source Northwell Health
Contact
Status Terminated
Phase Phase 4
Start date September 5, 2017
Completion date November 25, 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03218969 - Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist Phase 1/Phase 2
Completed NCT06280911 - The Effect of Consumption of Date Fruit and Nipple Stimulation in Late Pregnancy N/A
Not yet recruiting NCT05600608 - Augmentation of Volatile Biomarkers of Oesophageal and Gastric Adenocarcinoma From the Tumour Lipidome N/A
Active, not recruiting NCT05079243 - Dermal and Subcutaneous Augmentation and Skin Assessment After Fat-, Stem Cell and Scaffold Injections N/A
Withdrawn NCT00981266 - Spectra Breast Implant Study Phase 3
Recruiting NCT04266652 - Using the Roots of a Non Restorable Wisdom Tooth as a Block for Augmentation of Localized Defects Phase 4